Hamilton Introduces Automated DNA Sample Enrichment Solution using Roche 454 REM e System

Veröffentlicht am von
Pressemeldung der Firma Roche Diagnostics GmbH

Hamilton Robotics announced today a new automated solution for DNA sample enrichment on the MICROLAB STARlet Liquid Handling Workstation. Integrating Roche’s REM e liquid handling system, the workflow solution enriches up to eight DNA samples for subsequent sequencing on the GS FLX System. The integrated system automates the multiple-step enrichment process, resulting in reduced variability, more consistent results and significant time savings.

The Hamilton solution for REM e integration replaces five hours of dedicated manual work with an automated, walkaway procedure. Five different REM e protocols are available as fully automated STARlet methods. Predefined hardware to accurately position the REM e Deck module and the REM e Tube Racks on the STARlet deck are included with the solution. The REM e module performs vortexing, vacuum filtration, magnetic bead capture and heating. All liquid transfer steps are handled by the 1000 µL independent pipetting channels of the STARlet system.

454 Life Sciences, a Roche Company and Hamilton Company will continue to collaborate in developing automation solutions for the benchtop GS Junior System using the STAR and NIMBUS line products. REM e integration on the Hamilton MICROLAB NIMBUS workstation will offer customers a compact and affordable robotic platform for the lower-throughput needs of GS Junior customers.

About Hamilton Robotics

Hamilton is a leading worldwide supplier of precision liquid handling equipment, laboratory automation and storage systems, serving customers in academic and private research laboratories, pharmaceutical and clinical diagnostic companies and governmental institutions. Hamilton maintains headquarters in Reno, Nevada and Bonaduz, Switzerland, both of which house R&D and production facilities. Hamilton has subsidiaries for direct sales and service in many countries and works with a wide distributor network in other regions. Hamilton is a privately held company. For more information, visit www.hamiltonrobotics.com.

For life science research only. Not for use in diagnostic procedures.

454, 454 LIFE SCIENCES, 454 SEQUENCING, and GS FLX are trademarks of Roche.

All other product names and trademarks are the property of their respective owners.



Firmenkontakt und Herausgeber der Meldung:
Roche Diagnostics GmbH
Sandhofer Str. 116
68305 Mannheim
Telefon: +49 (621) 759-0
Telefax: +49 (621) 759-4083
http://www.roche.de/

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80,000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.


Weiterführende Links

Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die Huber Verlag für Neue Medien GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die Huber Verlag für Neue Medien GmbH gestattet.